OpenAI-backed Chai Discovery secured $130 million in Series B funding, reaching a $1.3 billion valua...
The AMW Read
Updates the player map for the Bio-platform vertical with a significant Series B round for Chai Discovery, though it does not trigger cross.§D as the funding is below the $500M threshold.
NoveltySignificance
Healthcare & Bio · Player Map
OpenAI-backed Chai Discovery secured $130 million in Series B funding, reaching a $1.3 billion valuation. This rapid financing, totaling $225 million in three months, highlights significant investor confidence in AI's role in drug discovery. The funds will advance their computer-aided design suite for molecules, accelerating the development of new therapeutics. This marks a pivotal step toward transforming the pharmaceutical industry with AI-driven molecular engineering.
#AI #DrugDiscovery #Biotech #OpenAI #VentureCapital #Pharma #Innovation
